Workflow
Autobio(603658)
icon
Search documents
安图生物(603658) - 2016 Q3 - 季度财报
2016-10-25 16:00
Financial Performance - Operating income for the first nine months rose by 35.43% to CNY 692,278,202.27 compared to the same period last year[6]. - Net profit attributable to shareholders increased by 29.00% to CNY 254,829,985.03 for the first nine months[6]. - The company's net profit for the first nine months increased by 93.05% to RMB 528,616,907.67, reflecting strong operational performance[14]. - The company reported a net profit of CNY 529,707,786.15, up from CNY 272,400,190.81, showing a year-on-year increase of 94.5%[25]. - Total operating revenue for Q3 reached ¥258.54 million, a 30.3% increase from ¥198.35 million in the same period last year[28]. - Net profit for Q3 was ¥107.09 million, a 21.0% increase from ¥88.54 million in the same quarter last year[30]. - Year-to-date operating revenue reached ¥692.28 million, a 35.4% increase from ¥511.17 million in the same period last year[28]. - Year-to-date net profit totaled ¥254.83 million, up 29.0% from ¥197.55 million in the previous year[30]. Assets and Liabilities - Total assets increased by 81.28% to CNY 1,714,095,727.85 compared to the end of the previous year[6]. - Current assets totaled CNY 1,080,498,673.75, up from CNY 388,171,299.03 at the beginning of the year, indicating a strong liquidity position[23]. - Total liabilities decreased to CNY 184,241,024.97 from CNY 227,539,078.73, representing a reduction of approximately 19%[24]. - Owner's equity increased to CNY 1,551,306,879.24 from CNY 717,386,207.32, marking a growth of about 116%[25]. - Accounts payable rose to CNY 67,695,553.11 from CNY 31,589,089.47, reflecting a 114% increase[24]. Cash Flow - Cash flow from operating activities increased by 24.27% to CNY 264,155,715.01 for the first nine months[6]. - The net cash flow from financing activities was RMB 482,652,170.63, significantly improving from a negative cash flow of RMB -4,851,524.35 in the previous year, due to new share issuance[14]. - The net cash flow from financing activities for the first nine months of 2016 was CNY 482,652,170.63, compared to a net outflow of CNY 4,851,524.35 in the same period last year[38]. - The ending cash and cash equivalents balance was $810.13 million, up from $126.08 million year-over-year, showing a substantial increase of 642.5%[42]. Shareholder Information - The total number of shareholders reached 28,439 by the end of the reporting period[11]. - The largest shareholder, Zhengzhou Antu Industrial Co., Ltd., holds 67.49% of the shares[11]. Expenses - The company's management expenses increased by 50.91% to RMB 100,625,423.47, primarily due to higher R&D expenditures[14]. - Sales expenses for Q3 were ¥29.02 million, an increase of 27.5% from ¥22.89 million year-over-year[28]. - Management expenses for Q3 rose to ¥35.32 million, a significant increase of 59.5% compared to ¥22.13 million in the same period last year[28]. Investments - Long-term equity investments surged by 1,165.04% to RMB 5,267,024.06, attributed to the completion of capital contributions to associated companies[13]. - Long-term investments increased to CNY 31,380,983.32 from CNY 25,030,312.17, indicating a growth of 25.5%[23]. Government Support - The company received government subsidies amounting to CNY 8,245,274.20 during the first nine months[8]. Inventory and Fixed Assets - The company's fixed assets rose by 78.03% to RMB 439,547,429.87, mainly due to the commissioning of new factory facilities[13]. - Inventory rose to CNY 109,748,019.12 from CNY 92,797,971.12, showing an 18.2% increase[23].